Gunter Auerswald
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Normalization of Haemostasis in People with Haemophilia A: Expert Consensus on Unmet Needs and a Framework for Advancing Towards Health Equity.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: January 14, 2026
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study.
Journal: Therapeutic advances in hematology
Published: July 06, 2025
Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL Study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 26, 2024
Clinical, Obstetric-Gynaecological and HRQoL Data of Female VWD Patients in the WIL-QoL Study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 26, 2024
A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease.
Journal: Thrombosis and haemostasis
Published: January 25, 2024
The WIL-QoL study: How it all began.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 30, 2022
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency.
Journal: Blood reviews
Published: October 05, 2020
An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study).
Journal: Journal of blood medicine
Published: June 24, 2020
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 18, 2019
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 04, 2019
Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study).
Journal: Journal of blood medicine
Published: October 31, 2019
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.
Journal: European journal of haematology
Published: July 30, 2018
Last Updated: 09/26/2026